BACKGROUND: Today's diabetes-oriented telemedicine systems can gather and analyze many parameters like blood glucose levels, carbohydrate intake, insulin doses, and physical activity levels (steps). Information collected can be presented to patients in a variety of graphical outputs. Despite the availability of several technical means, a large percentage of patients do not reach the goals established in their diabetes treatment. OBJECTIVE: The objective of the study was to evaluate the benefits of the Diani telemedicine system for the treatment of patients with type 1 diabetes mellitus. METHODS: Data were collected during a 24-week feasibility study. Patients responded to the World Health Organization Quality of Life - BREF (WHOQOL-BREF) questionnaire and a system evaluation questionnaire. The level of glycated hemoglobin (HbA1c) and the patient's body weight were measured, and the patient's use of the telemedicine system and their daily physical activity level were monitored. All data were sent from the patient's device to the Diani server using a real-time diabetes diary app. Wilcoxon and Friedman tests and the linear mixed effects method were used for data analysis. RESULTS: This study involved 10 patients (men: n=5; women: n=5), with a mean age of 47.7 (SD 19.3) years, a mean duration of diabetes of 10.5 (SD 8.6) years, and a mean HbA1c value of 59.5 (SD 6.7) mmol/mol. The median number of days the patients used the system was 84. After the intervention, the mean HbA1c decreased by 4.35 mmol/mol (P=.01). The patients spent 18.6 (SD 6.8) minutes on average using the app daily. After the intervention, the number of patients who measured their blood glucose level at least 3 times a day increased by 30%. The graphical visualization of the monitored parameters, automatic transmission of measured data from the glucometer, compatibility, and interconnection of individual devices when entering data were positively evaluated by patients. CONCLUSIONS: The Diani system was found to be beneficial for patients with type 1 diabetes mellitus in terms of managing their disease. Patients perceived it positively; it strengthened their knowledge of diabetes and their understanding of the influences of the measured values on the management of their disease. Its use had a positive effect on the HbA1c level.

1st Faculty of Medicine Charles University Prague Czech Republic

Department of Information and Communication Technologies in Medicine Faculty of Biomedical Engineering Czech Technical University Prague Praha Czech Republic

Department of Internal Medicine 2nd Medical Faculty Charles University and Motol University Hospital Prague Czech Republic

Department of Internal Medicine Faculty Hospital Kralovske Vinohrady Center for Research in Diabetes Metabolism and Nutrition Charles University 3rd Faculty of Medicine Prague Czech Republic

Institute of Computer Science Academy of Science of the Czech Republic Prague Czech Republic

Norwegian Centre for E health Research Tromsø Norway

University of Tromsø The Arctic University of Norway Tromsø Norway

Zobrazit více v PubMed

Global report on diabetes. World Health Organization. 2016. [2023-03-31]. https://apps.who.int/iris/handle/10665/204871 .

IDF Diabetes Atlas, 10th ed. Brussels: International Diabetes Federation; 2021.

You WP, Henneberg M. Type 1 diabetes prevalence increasing globally and regionally: the role of natural selection and life expectancy at birth. BMJ Open Diabetes Res Care. 2016;4(1):e000161. doi: 10.1136/bmjdrc-2015-000161. bmjdrc-2015-000161 PubMed DOI PMC

Gregory GA, Robinson TIG, Linklater SE, Wang F, Colagiuri S, de Beaufort C, Donaghue KC, International Diabetes Federation Diabetes Atlas Type 1 Diabetes in Adults Special Interest Group. Magliano DJ, Maniam J, Orchard TJ, Rai P, Ogle GD. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. Lancet Diabetes Endocrinol. 2022 Oct;10(10):741–760. doi: 10.1016/S2213-8587(22)00218-2.S2213-8587(22)00218-2 PubMed DOI

Fang M, Wang D, Coresh J, Selvin E. Trends in Diabetes Treatment and Control in U.S. Adults, 1999-2018. N Engl J Med. 2021 Jun 10;384(23):2219–2228. doi: 10.1056/NEJMsa2032271. PubMed DOI PMC

Taloyan M, Kia M, Lamian F, Peterson M, Rydwik E. Web-based support for individuals with type 2 diabetes - a feasibility study. BMC Health Serv Res. 2021;21(1):1–721. doi: 10.54394/wevn1114. PubMed DOI PMC

Miller KM, Foster NC, Beck RW, Bergenstal RM, DuBose SN, DiMeglio LA, Maahs DM, Tamborlane WV, T1D Exchange Clinic Network Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care. 2015 Jun;38(6):971–8. doi: 10.2337/dc15-0078.38/6/971 PubMed DOI

Brož J, Janíčková Žďárská D, Urbanová J, Brabec M, Doničová V, Štěpánová R, Martinka E, Kvapil M. Current level of glycemic control and clinical inertia in subjects using insulin for the treatment of type 1 and type 2 diabetes in the Czech Republic and the Slovak Republic: results of a multinational, multicenter, observational survey (DIAINFORM) Diabetes Ther. 2018;9(5):1897–1906. doi: 10.1007/s13300-018-0485-2. 10.1007/s13300-018-0485-2 PubMed DOI PMC

Faruque LI, Wiebe N, Ehteshami-Afshar A, Liu Y, Dianati-Maleki N, Hemmelgarn BR, Manns BJ, Tonelli M, Alberta Kidney Disease Network Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trials. Can Med Assoc J. 2017;189(9):E341–E364. doi: 10.1503/cmaj.150885. cmaj.150885 PubMed DOI PMC

Holubová A, Vlasáková M, Mužík J, Brož J. Customizing the types of technologies used by patients with type 1 diabetes mellitus for diabetes treatment: case series on patient experience. JMIR Mhealth Uhealth. 2019;7(7):e11527. doi: 10.2196/11527. v7i7e11527 PubMed DOI PMC

Hangaard S, Laursen S, Udsen F, Vestergaard P, Hejlesen O. Telemedicine interventions for the management of diabetes: a systematic review and meta-analysis. Stud Health Technol Inform. 2020;270:1403–1404. doi: 10.3233/SHTI200463.SHTI200463 PubMed DOI

Jaana M, Paré G. Home telemonitoring of patients with diabetes: a systematic assessment of observed effects. J Eval Clin Pract. 2006;13(2):242–253. doi: 10.1111/j.1365-2753.2006.00686.x.JEP686 PubMed DOI

Glasgow RE, Boles SM, McKay HG, Feil EG, Barrera M. The D-Net diabetes self-management program: long-term implementation, outcomes, and generalization results. Prev Med. 2003;36(4):410–409. doi: 10.1016/s0091-7435(02)00056-7.S0091743502000567 PubMed DOI

Mignerat M, Lapointe L, Vedel I. Using telecare for diabetic patients: a mixed systematic review. Health Policy Technol. 2014;3(2):90–112. doi: 10.1016/j.hlpt.2014.01.004. DOI

Turnin M, Gourdy P, Martini J, Buisson J, Chauchard M, Delaunay J, Schirr-Bonnans S, Taoui S, Poncet M, Cosma V, Lablanche S, Coustols-Valat M, Chaillous L, Thivolet C, Sanz C, Penfornis A, Lepage B, Colineaux H, Mounié M, Costa N, Molinier L, Hanaire H, Educ@dom Study Group Impact of a remote monitoring programme including lifestyle education software in type 2 diabetes: results of the Educ@dom randomised multicentre. Diabetes Ther. 2021;12(7):2059–2075. doi: 10.1007/s13300-021-01095-x. 10.1007/s13300-021-01095-x PubMed DOI PMC

Beck RW, Miller KM, Foster NC. The T1D exchange clinic network and registry: 10 years of enlightenment on the state of type 1 diabetes in the United States. Diabetes Technol Ther. 2019;21(6):310–312. doi: 10.1089/dia.2019.0129. PubMed DOI

Polisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K. Home telehealth for diabetes management: a systematic review and meta-analysis. Diabetes Obes Metab. 2009;11(10):913–930. doi: 10.1111/j.1463-1326.2009.01057.x.DOM1057 PubMed DOI

Quinn CC, Clough SS, Minor JM, Lender D, Okafor MC, Gruber-Baldini A. WellDoc mobile diabetes management randomized controlled trial: change in clinical and behavioral outcomes and patient and physician satisfaction. Diabetes Technol Ther. 2008;10(3):160–168. doi: 10.1089/dia.2008.0283.10.1089/dia.2008.0283 PubMed DOI

Eberle C, Stichling S. Clinical improvements by telemedicine interventions managing type 1 and type 2 diabetes: systematic meta-review. J Med Internet Res. 2021;23(2):e23244. doi: 10.2196/23244. v23i2e23244 PubMed DOI PMC

Niu XD, Chi JT, Guo JB, Ruan HH, Zhang J, Tao HX, Wang Y. Effects of nurse-led web-based interventions on people with type 2 diabetes mellitus: A systematic review and meta-analysis. J Telemed Telecare. 2021 Jun;27(5):269–279. doi: 10.1177/1357633X211010019. PubMed DOI

Brož J, Holubová A, Mužík J, Vlasáková M, Mužný M, Králová A, Hoskovcová L, Janíčková Zďárská D, Arsand E, Hronová M, Urbanová J, Kvapil M. Long term use of the telemonitoring system Diani in the therapy of a patient with type 1 diabetes. Vnitr Lek. 2020;66(4):87–91.123929 PubMed

Tran VT, Montori VM, Ravaud P. Is My Patient Overwhelmed?: Determining Thresholds for Acceptable Burden of Treatment Using Data From the ComPaRe e-Cohort. Mayo Clin Proc. 2020 Mar;95(3):504–512. doi: 10.1016/j.mayocp.2019.09.004.S0025-6196(19)30770-0 PubMed DOI

Schneeweiss S, Patorno E. Conducting real-world evidence studies on the clinical outcomes of diabetes treatments. Endocr Rev. 2021;42(5):658–690. doi: 10.1210/endrev/bnab007. 6169054 PubMed DOI PMC

Saturni S, Bellini F, Braido F, Paggiaro P, Sanduzzi A, Scichilone N, Santus PA, Morandi L, Papi A. Randomized controlled trials and real life studies. Approaches and methodologies: a clinical point of view. Pulm Pharmacol Ther. 2014;27(2):129–138. doi: 10.1016/j.pupt.2014.01.005.S1094-5539(14)00017-0 PubMed DOI

Brož J, Holubová A, Mužík J, Oulická M. Diabetes Technol Ther. 2016 Feb;18 Suppl 1:A1–139. doi: 10.1089/dia.2016.2525. PubMed DOI

Holubova A, Muzik J, Arsand E, Muzny M, Broz J, Vlasakova M. Alerts, notifications, reminders: telemedicine solution not to burden but to support patients with diabetes. Diabetes Technol Ther. 2016:226. doi: 10.1089/dia.2016.2525. PubMed DOI

Anderson K, Burford O, Emmerton L. Mobile health apps to facilitate self-care: a qualitative study of user experiences. PLoS One. 2016;11(5):e0156164. doi: 10.1371/journal.pone.0156164. PONE-D-16-02829 PubMed DOI PMC

Luley C, Blaik A, Reschke K, Klose S, Westphal S. Weight loss in obese patients with type 2 diabetes: effects of telemonitoring plus a diet combination - the active body control (ABC) Program. Diabetes Res Clin Pract. 2010;91(3):286–292. doi: 10.1016/j.diabres.2010.11.020.S0168-8227(10)00572-3 PubMed DOI

Quinn CC, Gruber-Baldini AL, Shardell M, Weed K, Clough SS, Peeples M, Terrin M, Bronich-Hall L, Barr E, Lender D. Mobile diabetes intervention study: testing a personalized treatment/behavioral communication intervention for blood glucose control. Contemp Clin Trials. 2009;30(4):334–346. doi: 10.1016/j.cct.2009.02.004.S1551-7144(09)00034-2 PubMed DOI

Farmer AJ, Gibson OJ, Dudley C, Bryden K, Hayton PM, Tarassenko L, Neil A. A randomized controlled trial of the effect of real-time telemedicine support on glycemic control in young adults with type 1 diabetes (ISRCTN 46889446) Diabetes Care. 2005;28(11):2697–2702. doi: 10.2337/diacare.28.11.2697.28/11/2697 PubMed DOI

Quinn CC, Shardell MD, Terrin ML, Barr EA, Ballew SH, Gruber-Baldini AL. Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care. 2011;34(9):1934–1942. doi: 10.2337/dc11-0366. dc11-0366 PubMed DOI PMC

The WHOQOL Group Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28(3):551–558. doi: 10.1017/s0033291798006667. PubMed DOI

Dragomericka E. Prediktory kvality zivota ve vyssím veku. Dizertacní práce. 2007. [2023-03-12]. https://www.researchgate.net/profile/Monika_Kacmarova/publication/338751181_Kvalita_zivota_2019_final/links/5e287d4e4585150ee77b221d/Kvalita-zivota-2019-final.pdf .

Lewis Jr. Psychometric evaluation of the PSSUQ using data from five years of usability studies. Int J Hum Comput Stud. 2002 Sep;14(3-4):463–488. doi: 10.1080/10447318.2002.9669130. DOI

McNair JB. Handbook of Evaluation Methods for Health Informatics. Cambridge: Elsevier Academic Press; 2006.

AlDossary S, Martin-Khan MG, Bradford NK, Smith AC. A systematic review of the methodologies used to evaluate telemedicine service initiatives in hospital facilities. Int J Med Inform. 2017;97:171–194. doi: 10.1016/j.ijmedinf.2016.10.012. S1386-5056(16)30227-1 PubMed DOI

Klaassen B, van Beijnum BJ, Hermens HJ. Usability in telemedicine systems-a literature survey. Int J Med Inform. 2016;93:57–69. doi: 10.1016/j.ijmedinf.2016.06.004.S1386-5056(16)30130-7 PubMed DOI

Kaloricke tabulky osobní pomocnik pro vyzivu. Hradec Kralove Dine4Fit. [2023-03-23]. https://www.kaloricketabulky.cz/

Vluggen S, Hoving C, Vonken L, Schaper NC, de Vries H. Exploring factors influencing recruitment results of nurses recruiting diabetes patients for a randomized controlled trial. Clin Trials. 2020;17(4):448–458. doi: 10.1177/1740774520914609. PubMed DOI PMC

Eberle C, Stichling S. Effect of telemetric interventions on glycated hemoglobin A1c and management of type 2 diabetes mellitus: systematic meta-review. J Med Internet Res. 2021;23(2):e23252. doi: 10.2196/23252. v23i2e23252 PubMed DOI PMC

von Storch K, Graaf E, Wunderlich M, Rietz C, Polidori MC, Woopen C. Telemedicine-assisted self-management program for type 2 diabetes patients. Diabetes Technol Ther. 2019;21(9):514–521. doi: 10.1089/dia.2019.0056. PubMed DOI

Stakeholder Insights into Czech Performance-Based Managed Entry Agreements: Potential for Transformative Change in Pharmaceutical Access?